Finance

Beta
Mga Listahan
Mga sektor ng equity
Mga Simbolo
Mga Simbolo
Presyo
Palitan
% ng Pagbabago
Trend
Nakaraang Pagsara
Buksan
Mataas
Mababa
Dami
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.99%
1,093.81
+10.77
+0.99%
—1,083.041,082.631,099.011,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+1.06%
608.77
+6.39
+1.06%
—602.38602.38609.75599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.96%
1,254.81
+11.98
+0.96%
—1,242.831,229.311,258.881,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2.76%
1,761.11
+47.29
+2.76%
—1,713.821,715.471,763.111,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.40%
642.58
+2.59
+0.40%
—639.99636.98644.04631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.63%
851.13
+13.67
+1.63%
—837.46840.30852.55840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.76%
217.98
+3.76
+1.76%
—214.22214.22218.25214.05——
SIXT
Technology
SIXT
Technology
SIXT
+0.23%
3,211.83
+7.45
+0.23%
—3,204.383,215.043,217.443,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.55%
948.98
+23.60
+2.55%
—925.38927.91949.76927.91——
SIXV
Health care
SIXV
Health care
SIXV
+2.20%
1,474.52
+31.81
+2.20%
—1,442.711,443.011,477.901,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.30%
2,392.12
+30.78
+1.30%
—2,361.342,391.002,399.182,354.52——
ROGP:VIE
Roche
€346.00
+1.17%
(+4.00) 1D
Abr 30, 5:36:00 PM GMT+2  ·   EUR
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa ROGP...
Buksan
€343.00
Mataas
€348.00
Mababa
€343.00
Mkt. cap
328.40B
Avg. na dami
3.00
Dami
0.00
Mataas nang 52-wk
€354.00
Mababa nang 52-wk
€331.00
Bilang ng mga empleyado
113K
Mga balita at kwento
Mula sa mga source sa buong web
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Tungkol sa Roche
CEOThomas Schinecker
Mga Empleyado113K
ItinatagOkt 1, 1896
HeadquartersBasel, Basel City, Switzerland
Sektor-
Websiteroche.com
Mga nakaraang ulatLahat ng value sa CHF
Loading Previous Earnings...
Statement ng kita
Kita
Net na kita
Lahat ng value sa CHF
Mar 2025
Hun 2025
Set 2025
Dis 2025
Kita
15.92B
15.92B
15.75B
15.75B
Gastusin sa mga naibentang produkto
3.87B
3.87B
4.21B
4.21B
Halaga ng kita
3.87B
3.87B
4.21B
4.21B
Mga gastos sa pananaliksik at pag-develop
3.11B
3.11B
3.15B
3.15B
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
3.29B
3.29B
3.59B
3.59B
Gastos sa pagpapatakbo
6.30B
6.30B
6.82B
6.82B
Kabuuang gastos sa pagpapatakbo
10.17B
10.17B
11.03B
11.03B
Kita sa pagpapatakbo
5.75B
5.75B
4.72B
4.72B
Iba pang hindi kita sa pagpapatakbo
4.00M
4.00M
-1.50M
-1.50M
EBT na may mga hindi karaniwang item
4.79B
4.79B
3.69B
3.69B
EBT na hindi kasama ang mga hindi karaniwang item
5.46B
5.46B
4.37B
4.37B
Gastos sa buwis sa kita
878.00M
878.00M
709.00M
709.00M
Epektibong rate ng buwis
18.31%
18.31%
19.20%
19.20%
Iba pang gastos sa pagpapatakbo
-110.50M
-110.50M
77.50M
77.50M
Net na kita
3.70B
3.70B
2.74B
2.74B
Margin ng kabuuang kita
23.27%
23.27%
17.36%
17.36%
Kita bawat share
-
-
-
-
Kita sa interes at investment
56.50M
56.50M
45.00M
45.00M
Gastos sa interes
-304.00M
-304.00M
-289.50M
-289.50M
Mga net na gastos sa interes
-247.50M
-247.50M
-244.50M
-244.50M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
6.53B
6.53B
5.50B
5.50B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-
-21.50M
-21.50M
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
TulongMagpadala ng feedbackPrivacyMga TuntuninDisclaimer

Pananaliksik

Mga gawain ko
Wala ka pang nagagawang gawain
Lalabas dito ang iyong mga gawain. Mag-iskedyul ng mga gawain at gamitin ang Google Finance habang wala ka.
Mga Template
Briefing ng watchlist
Pang-araw-araw na pagsusuri sa iyong watchlist bago magbukas ang market
Mga Paparating na Kita
Mga paparating na ulat ng mga kita sa linggo
Abnormal na Volatility at Dami
Maagang babala sa volatility at dami ngayong araw
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
TulongMagpadala ng feedbackPrivacyMga TuntuninDisclaimer